Novo Integrated Sciences to Present at the Benzinga Virtual Global Healthcare Small Cap Conference on September 30th
2021年9月23日 - 9:00PM
ビジネスワイヤ(英語)
Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the “Company” or
“Novo”), pioneering a holistic approach to patient-first health and
wellness through a multidisciplinary healthcare ecosystem of
services and product innovation, today announced that Robert
Mattacchione, Chairman and CEO, is scheduled to present at the
Benzinga Virtual Global Healthcare Small Cap Conference.
Benzinga Virtual Global Healthcare
Small Cap Conference Thursday, September 30th at 1:15
p.m. ET Registration:
https://www.benzinga.com/events/small-cap/healthcare/
The Novo management team will be available for one-on-one
meetings for the duration of the conference. To schedule a meeting
or for more information on the conference, please contact your
Benzinga representative, or Chris David, COO-President, at
chris.david@novointegrated.com.
About Novo Integrated Sciences,
Inc.
Novo Integrated Sciences, Inc. is pioneering a holistic approach
to patient-first health and wellness through a multidisciplinary
healthcare ecosystem of services and product innovation. Novo
offers an essential and differentiated solution to deliver, or
intend to deliver, these services and products through the
integration of medical technology, advanced therapeutics, and
rehabilitative science.
We believe that “decentralizing” healthcare, through the
integration of medical technology and interconnectivity offers an
essential solution to the fundamental transformation of healthcare
delivery. Specific to non-critical care, ongoing advancements in
both medical technology and inter-connectivity are allowing for a
shift of the patient/practitioner relationship to the patient’s
home and away from on-site visits to primary medical centers with
mass-services. This acceleration of “ease-of-access” in the
patient/practitioner interaction for non-critical care diagnosis
and subsequent treatment minimizes the degradation of non-critical
health conditions to critical conditions as well as allowing for
more cost-effective healthcare distribution.
Novo’s decentralized healthcare business model is centered on
three primary pillars to best support the transformation of
non-catastrophic healthcare delivery to patients and consumers. The
first pillar is building a foundation of traditional hands-on
healthcare delivery, through small and micro footprint sized clinic
facilities, within a significant service delivery network. The
second pillar is the development, integration, and deployment of
sophisticated technology, through interconnectivity, which expands
the reach of healthcare related service, beyond the traditional
clinic location, to geographic areas not readily providing advanced
healthcare service to date, including the patient’s home. The third
pillar is the development and distribution of effective wellness
product solutions allowing for the customization of patient
preventative care remedies and ultimately a healthier population.
Additionally, Novo’s science first approach to product innovation
further emphasizes Novo’s mandate to create and provide
over-the-counter preventative and maintenance care solutions.
Innovation in science as represented by proprietary technology
assures Novo of continued cutting edge advancement in patient first
platforms.
For more information concerning Novo Integrated Sciences, please
visit www.novointegrated.com . For more information on NHL,
please visit www.novohealthnet.com.
Twitter: https://twitter.com/novointegrated LinkedIn:
https://www.linkedin.com/company/60376520/admin/ Facebook:
https://www.facebook.com/novointegrated/ Instagram:
https://www.instagram.com/novointegrated/ YouTube:
https://www.youtube.com/channel/UCy3wpEIfQwwaf0BZ-34OKwQ
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210923005122/en/
Chris David, COO-President Novo Integrated Sciences, Inc.
chris.david@novointegrated.com (888) 512-1195
Novo Integrated Sciences (NASDAQ:NVOS)
過去 株価チャート
から 6 2024 まで 7 2024
Novo Integrated Sciences (NASDAQ:NVOS)
過去 株価チャート
から 7 2023 まで 7 2024